- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.47 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x D4J: (2S)-5-[(2-chlorophenyl)sulfanyl]-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
D4J.2: 13 residues within 4Å:- Chain A: N.137, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.1
11 PLIP interactions:11 interactions with chain A- Hydrophobic interactions: A:V.234, A:A.237, A:I.241, A:I.241, A:I.241
- Hydrogen bonds: A:N.137, A:R.168, A:R.168, A:H.192, A:T.247
- pi-Stacking: A:Y.238
D4J.7: 14 residues within 4Å:- Chain C: Q.99, N.137, D.165, R.168, H.192, G.193, D.194, V.233, V.234, A.237, Y.238, I.241, T.247
- Ligands: NAD.6
11 PLIP interactions:11 interactions with chain C- Hydrophobic interactions: C:A.237, C:I.241, C:I.241, C:I.241
- Hydrogen bonds: C:N.137, C:R.168, C:R.168, C:H.192, C:T.247, C:T.247
- pi-Stacking: C:Y.238
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 2 x LAC: LACTIC ACID(Non-covalent)
LAC.5: 9 residues within 4Å:- Chain B: Q.99, R.105, N.137, L.164, R.168, H.192, A.237, T.247
- Ligands: NAD.3
9 PLIP interactions:9 interactions with chain B- Hydrogen bonds: B:Q.99, B:R.105, B:N.137, B:H.192, B:T.247
- Water bridges: B:A.237
- Salt bridges: B:R.105, B:R.168, B:H.192
LAC.9: 9 residues within 4Å:- Chain D: Q.99, R.105, N.137, L.164, R.168, H.192, A.237, T.247
- Ligands: NAD.8
9 PLIP interactions:9 interactions with chain D- Hydrophobic interactions: D:T.247
- Hydrogen bonds: D:Q.99, D:R.105, D:N.137, D:H.192, D:T.247
- Salt bridges: D:R.105, D:R.168, D:H.192
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.47 Å
- Oligo State
- homo-tetramer
- Ligands
- 4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- 2 x D4J: (2S)-5-[(2-chlorophenyl)sulfanyl]-6'-(4-fluorophenoxy)-4-hydroxy-2-(thiophen-3-yl)-2,3-dihydro[2,2'-bipyridin]-6(1H)-one(Non-covalent)
- 1 x SO4: SULFATE ION(Non-functional Binders)
- 2 x LAC: LACTIC ACID(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Wei, B. et al., Structure-guided optimization and in vivo activities of hydroxylactone and hydroxylactam Inhibitors of Human Lactate Dehydrogenase. To Be Published
- Release Date
- 2018-10-24
- Peptides
- L-lactate dehydrogenase A chain: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
EB
FC
GD
H